Huons & KRICT’s co-development agreement of targeted liver disease therapy
Huons(CEO Ki-Ahn Um) will take joint development of a new drug for liver diseases with the Korea Research Institute of Chemical Technology.
Huons and the Korea Research Institute of Chemical Technology(KRICT) announced a co-development of a new drug for liver diseases using the ‘Proteolysis-Targ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
